🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Such an amazing weekend - first paper accepted and we're finally allowed to leave the city again 🥳☀️

Oh the associations we make-is GIP guilty as charged? What do plasma levels of GIP and GLP-1 tell you about metabolic control #obesity #insulin resistance or risk of #CVD #T2D care.diabetesjournals.org/content/early/…

So happy to share our work on #pharmacokinetics of #GIP in mice. Worth a read if you're planning studies involving exogenous GIP administration in mice and/or determination of Total/Intact GIP levels. Elsevier Endocrinology & Diabetes NNF Center for Basic Metabolic Research (CBMR) #incretins #diabetes #obesity doi.org/10.1016/j.pept…

Great first day at the Virtual Keystone Symposia Obesity: From Cell to Patient. Very excited to present our work on the GIPR knockout mouse model in a short talk tomorrow! #GIP #obesity #keystone

So glad to share our work on the GIPR KO mouse model. Thanks Matthew Watt for your great guidance and for hosting me in your lab these past 18 months. And thanks Stacey Nicole Keenan & Paula Miotto for being awesome lab-lockdown buddies and all your help with the project🐀🥼😊

I should probably find another hobby 😅 University of Otago

First publication for me as a postdoc in the Tups lab. A review on #GIP, #GLP-1 and their effects on body weight via signalling in the central nervous system. Read it here: authors.elsevier.com/a/1gAVLbg0khAvK Trends in Pharmacological Sciences

I am very grateful to HRC New Zealand for awarding me an HRC Emerging Researcher First Grant. This grant will allow me to dive further into the world of GIP and its role in healthy ageing. More info on the project here: hrc.govt.nz/resources/rese… #GIP #ageing #HRC #CNE